Cargando…

Is It Time to Screen the General Population for Type 1 Diabetes?

Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by destruction of insulin-producing β cells in the pancreas. The incidence of T1D is increasing dramatically, and the prevalence has doubled in the last 2 decades, further increasing the morbidity and mortality associated with the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simmons, Kimber M, Michels, Aaron W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731943/ https://www.ncbi.nlm.nih.gov/pubmed/33312232 http://dx.doi.org/10.17925/use.2015.11.1.10

Ejemplares similares

Screening children for type 1 diabetes-associated antibodies at community health fairs
por: Simmons, Kimber M., et al.
Publicado: (2019)

Failed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02
por: Simmons, Kimber M., et al.
Publicado: (2020)

Self-Antigens Targeted by Regulatory T Cells in Type 1 Diabetes
por: Mitchell, Angela M., et al.
Publicado: (2022)

Using the T Cell Receptor as a Biomarker in Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2021)

Determining Antigen Specificity of Human Islet Infiltrating T Cells in Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2019)

Proinsulin:C-peptide ratio trajectories over time in relatives at increased risk of progression to type 1 diabetes
por: Triolo, Taylor M., et al.
Publicado: (2021)

Prediction of Type 1 Diabetes in the General Population
por: Knip, Mikael, et al.
Publicado: (2010)

High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously
por: Gu, Yong, et al.
Publicado: (2019)

Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes
por: Wenzlau, Janet M., et al.
Publicado: (2023)

Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes
por: Simmons, Kimber M., et al.
Publicado: (2019)

Enhancing the Understanding of Pre-Type 1 Diabetes in the General Population
por: Simell, Olli, et al.
Publicado: (2010)

Islet Autoantibody Measurements from Dried Blood Spots on Filter Paper Strongly Correlate to Serum Levels
por: Simmons, Kimber M., et al.
Publicado: (2016)

Overweight and obesity in type 1 diabetes equal those of the general population
por: Fellinger, Paul, et al.
Publicado: (2019)

EarLy Surveillance for Autoimmune diabetes: protocol for a qualitative study of general population and stakeholder perspectives on screening for type 1 diabetes in the UK (ELSA 1)
por: Quinn, Lauren Marie, et al.
Publicado: (2022)

Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: A randomised controlled trial in British general practice
por: Park, Paul, et al.
Publicado: (2008)

Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes
por: Baker, Rocky L., et al.
Publicado: (2019)

Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY)
por: Waugh, Kathleen, et al.
Publicado: (2017)

Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes
por: Ólafsdóttir, Arndís Finna, et al.
Publicado: (2019)

Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study
por: Raab, Jennifer, et al.
Publicado: (2016)

Heart Rate Variability and Incident Type 2 Diabetes in General Population
por: Wang, Kan, et al.
Publicado: (2023)

Patients with type 1 diabetes in Sweden experience more fatigue than the general population
por: Segerstedt, Johan, et al.
Publicado: (2015)

Human islet T cells are highly reactive to preproinsulin in type 1 diabetes
por: Anderson, Amanda M., et al.
Publicado: (2021)

Immunoreactive Trypsinogen and Free Carnitine Changes on Newborn Screening after Birth in Patients Who Develop Type 1 Diabetes
por: Estrella, Jane Frances Grace Lustre, et al.
Publicado: (2021)

Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study
por: Chamnan, P, et al.
Publicado: (2012)

Proinsulin-Reactive CD4 T Cells in the Islets of Type 1 Diabetes Organ Donors
por: Landry, Laurie G., et al.
Publicado: (2021)

Effect of screening for Type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort
por: Rahman, M, et al.
Publicado: (2012)

Effective assay technologies fit for large-scale population screening of type 1 diabetes
por: Jia, Xiaofan, et al.
Publicado: (2023)

Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population
por: Sokooti, Sara, et al.
Publicado: (2020)

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial
por: Simmons, Rebecca K, et al.
Publicado: (2012)

Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults
por: Simmons, Rebecca K., et al.
Publicado: (2017)

The Promise and Peril of Genomic Screening in the General Population
por: Adams, Michael C., et al.
Publicado: (2015)

Fasting Ketone Bodies and Incident Type 2 Diabetes in the General Population
por: Szili-Torok, Tamas, et al.
Publicado: (2023)

Validation of DIABSCORE in screening for Type 2 Diabetes and prediabetes in Tunisian population
por: Gannar, Fadoua, et al.
Publicado: (2018)

Is It Time to Take a Different Approach to Screening People at High Risk for Type 1 Diabetes?
por: Boyko, Edward J., et al.
Publicado: (2009)

Fasting Proinsulin Independently Predicts Incident Type 2 Diabetes in the General Population
por: Sokooti, Sara, et al.
Publicado: (2022)

Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population
por: De Santi, F., et al.
Publicado: (2017)

Gestational Diabetes Mellitus: To Screen or Not to Screen?: Is this really still a question?
por: Simmons, David, et al.
Publicado: (2013)

Immune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis
por: Akturk, H. K., et al.
Publicado: (2019)

Normal fasting triglyceride levels and incident type 2 diabetes in the general population
por: Szili-Torok, Tamas, et al.
Publicado: (2022)

A Walk-In Screening of Dementia in the General Population in Taiwan
por: Chen, Chun-Hung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7pkvdcs3ftm09fbp6d45re9q4j